Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals

Neuropsychopharmacology

Volumn 33, Issue 4, 2008, Pages 827-836

  Streeter, Chris C ^a,b,c   Terhune, Devin B ^a   Whitfield, Theodore H ^d   Gruber, Staci ^b,c   Sarid Segal, Ofra ^a,e   Silveri, Marisa M ^b,c   Tzilos, Golfo ^f   Afshar, Maryam ^a   Rouse, Elizabeth D ^b   Tian, Hua ^a   Renshaw, Perry F ^a,b,c   Ciraulo, Domenic A ^a,c,e   Yurgelun Todd, Deborah A ^b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCLEAN HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Biostatistics Solutions Consulting   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; Compliance; Executive function; Neuropsychological testing; Prefrontal; Stroop

Indexed keywords

ADULT; ARTICLE; COCAINE DEPENDENCE; COGNITIVE DEFECT; COLOR NAMING; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HAMILTON SCALE; HUMAN; INTERFERENCE SUBTEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; STROOP TASK; TASK PERFORMANCE; WORD READING;

ADULT; ANALYSIS OF VARIANCE; COCAINE-RELATED DISORDERS; COLOR PERCEPTION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PATIENT COMPLIANCE; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; READING; SENSITIVITY AND SPECIFICITY;

EID: 39149116686     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301465     Document Type: Article

References (82)

1. Aharonovich E, Hasin DS, Brooks AC, Liu X, Bisaga A, Nunes EV (2006). Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend 81: 313-322.
2. Aharonovich E, Nunes E, Hasin D (2003). Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug Alcohol Depend 71: 207-211.
3. Alterman AI, McKay JR, Mulvaney FD, McLellan AT (1996). Prediction of attrition from day hospital treatment in lower socioeconomic cocaine-dependent men. Drug Alcohol Depend 40: 227-233.
4. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC.
5. Ardila A, Rosselli M, Strumwasser S (1991). Neuropsychological deficits in chronic cocaine abusers. Int J Neurosci 57: 73-79.
6. Barch DM, Braver TS, Akbudak E, Conturo T, Ollinger J, Snyder A (2001). Anterior cingulate cortex and response conflict: effects of response modality and processing domain. Cereb Cortex 11: 837-848.
7. Bauer D, Cox WM (1998). Alcohol-related words are distracting to both alcohol abusers and non-abusers in the Stroop colour-naming task. Addiction 93: 1539-1542.
8. Beatty WW, Katzung VM, Moreland VJ, Nixon SJ (1995). Neuropsychological performance of recently abstinent alcoholics and cocaine abusers. Drug Alcohol Depend 37: 247-253.
9. Berger SP, Winhusen TM, Somoza EC, Harrer JM, Mezinskis JP, Leiderman DB et al (2005). A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence. Addiction 100(Suppl 1): 58-67.
10. Berry J, van Gorp WG, Herzberg DS, Hinkin C, Boone K, Steinman L et al (1993). Neuropsychological deficits in abstinent cocaine abusers: preliminary findings after two weeks of abstinence. Drug Alcohol Depend 32: 231-237.
11. Bisaga A, Aharonovich E, Garawi F, Levin FR, Rubin E, Raby WN et al (2005). Utility of lead-in period in cocaine dependence pharmacotherapy trials. Drug Alcohol Depend 77: 7-11.
12. Bolla K, Ernst M, Kiehl K, Mouratidis M, Eldreth D, Contoreggi C et al (2004). Prefrontal cortical dysfunction in abstinent cocaine abusers. J Neuropsychiatry Clin Neurosci 16: 456-464.
13. Bolla K, Rothman R, Cadet J (1999). Dose-related neurobehavioral effects of chronic cocaine use. J Neuropsychiatry Clin Neurosci 11: 361-369.
14. Bolla KI, Cadet JL, London ED (1998). The neuropsychiatry of chronic cocaine abuse. J Neuropsychiatry Clin Neurosci 10: 280-289.
15. Bolla KI, Funderburk FR, Cadet JL (2000). Differential effects of cocaine and cocaine alcohol on neurocognitive performance. Neurology 54: 2285-2292.
16. Bonson KR, Grant SJ, Contoreggi CS, Links JM, Metcalfe J, Weyl HL et al (2002). Neural systems and cue-induced cocaine craving. Neuropsychopharmacology 26: 376-386.
17. Carpenter K, Schreiber E, Church S, McDowell D (2006). Drug Stroop performance: relationships with primary substance of use and treatment outcome in a drug-dependent outpatient sample. Addict Behav 31: 174-181.
18. Carroll KM, Rounsaville BJ, Gordon LT, Nich C, Jatlow P, Bisighini RM et al (1994). Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch Gen Psychiatry 51: 177-187.
19. Carter CS, Braver TS, Barch DM, Botvinick MM, Noll D, Cohen JD (1998). Anterior cingulate cortex, error detection, and the online monitoring of performance. Science 280: 747-749.
20. Carter CS, Mintun M, Cohen JD (1995). Interference and facilitation effects during selective attention: an H215O PET study of Stroop task performance. Neuroimage 2: 264-272.
21. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP (1999). Limbic activation during cue-induced cocaine craving. Am J Psychiatry 156: 11-18.
22. Ciraulo D, Sarid-Segal O, Knapp C, Ciraulo A, LoCastro J, Bloch D et al (2005). Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole, and venlafaxine in cocaine dependence. Addiction 100(Suppl 1): 12-22.
23. Cohen JD, Dunbar K, McClelland JL (1990). On the control of automatic processes: a parallel distributed processing account of the Stroop effect. Psychol Review 97: 332-361.
24. Comalli Jr P, Wapner S, Werner H (1962). Interference effects of Stroop color-word test in childhood, adulthood, and aging. J Genet Psychol 100: 47-53.
25. Copersino ML, Serper MR, Vadhan N, Goldberg BR, Richarme D, Chou JC et al (2004). Cocaine craving and attentional bias in cocaine-dependent schizophrenic patients. Psychiatry Res 128: 209-218.
26. Cox W, Hogan L, Kristian M, Race J (2002). Alcohol attentional bias as a predictor of alcohol abusers' treatment outcome. Drug Alcohol Depend 68: 237-243.
27. Cox WM, Yeates GN, Regan CM (1999). Effects of alcohol cues on cognitive processing in heavy and light drinkers. Drug Alcohol Depend 55: 85-89.
28. de Lima MS, de Oliveira Soares BG, Reisser AA, Farrell M (2004). Pharmacological treatment of cocaine dependence: a systematic review. Addiction 97: 931-949.
29. Di Sclafani V, Tolou-Shams M, Price LJ, Fein G (2002). Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence. Drug Alcohol Depend 66: 161-171.
30. Elkashef A, Holmes TH, Bloch DA, Shoptaw S, Kampman K, Reid MS et al (2005). Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence. Addiction 100(Suppl 1): 91-101.
31. First MB, Spitzer R, Gibbon M, Williams J (1995). Structured Clinical Interview for DSM-IV Axis I Disorders: Patient Edition (SCID-I/P, Version 2.0). Biometric Research Dept, New York State University: New York.
32. Franken IHA (2003). Drug craving and addiction: integrating psychological and neuropsychological approaches. Prog Neuropsychopharmacol Biol Psychiatry 27: 563-579.
33. Franken IHA, Kroon LY, Weirs RW, Jansen A (2000). Selective cognitive processing of drug cues in heroin dependence. J Psychopharmacol 14: 395-400.
34. Franklin T, Acton P, Maldjian J, Gray J, Croft J, Dackis C et al (2002). Decreased gray matter concentration in the insular, orbitofrontal, cingulate and temporal cortices of cocaine patients. Biol Psychiatry 51: 134-142.
35. Golden CJ (1976). Identification of brain disorders by the Stroop Color and Word Test. J Clin Psychol 32: 654-658.
36. Goldstein RZ, Volkow ND (2002). Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159: 1642-1652.
37. Grant S, London ED, Newlin DB, Villemagne VL, Liu X, Contoreggi C et al (1996). Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci USA 93: 12040-12045.
38. Gross TM, Jarvik ME, Rosenblatt MR (1993). Nicotine abstinence produces content-specific Stroop interference. Psychopharmacology (Berlin) 110: 333-336.
39. Gruber SA, Rogowska J, Holcomb P, Soraci S, Yurgelun-Todd D (2002). Stroop performance in normal control subjects: an fMRI study. Neuroimage 16: 349-360.
40. Hamilton M (1967). Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6: 278-296.
41. Herning RI, King DE, Better WE, Cadet JL (1999). Neurovascular deficits in cocaine abusers. Neuropsychopharmacology 21: 110-118.
42. Hester R, Dixon V, Garavan H (2006). A consistent attentional bias for drug-related material in active cocaine users across word and picture versions of the emotional Stroop task. Drug Alcohol Depend 81: 251-257.
43. Hester R, Garavan H (2004). Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J Neurosci 24: 11017-11022.
44. Hser Y, Stark ME, Paredes A, Huang D, Anglin MD, Rawson R (2006). A 12-year follow-up of a treated cocaine-dependent sample. J Subst Abuse Treat 30: 219-226.
45. Jovanovski D, Erb S, Zakzanis KK (2005). Neurocognitive deficits in cocaine users: a quantitative review of the evidence. J Clin Exp Neuropsychol 27: 189-204.
46. Kang SY, Kleinman PH, Woody GE, Millman RB, Todd TC, Kemp J et al (1991). Outcomes of cocaine abusers after once-a-week psychotherapy. Am J Psychiatry 148: 630-635.
47. Kaufman J, Ross T, Stein E, Garavan H (2003). Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging. J Neurosci 23: 7839-7843.
48. Ke Y, Streeter CC, Nassar LE, Sarid-Segal O, Hennen J, Yurgelun-Todd DA et al (2004). Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study. Psychiatry Res 130: 283-293.
49. Kiehl KA, Liddle PF, Hopfinger JB (2000). Error processing and the rostral anterior cingulate: an event-related fMRI study. Psychophysiology 37: 216-223.
50. King AC, Canada SA (2004). Client-related predictors of early treatment drop-out in a substance abuse clinic exclusively employing individual therapy. J Subst Abuse Treat 26: 189-195.
51. Leiderman DB, Shoptaw S, Montgomery A, Bloch DA, Elkashef A, LoCastro J et al (2005). Cocaine Rapid Efficacy Screening Trial (CREST): a paradigm for the controlled evaluation of candidate medications for cocaine dependence. Addiction 100(Suppl 1): 1-11.
52. Liederman D, Winhusin T, Somoza E, Montgomery A, Berger P (2000). A modified placebo controlled study for the treatment of cocaine dependence using reserpine, gabapentin, or lamotrigine versus an unmatched placebo (CREST-I). Study Report, NIDA.
53. Lim KO, Choi SJ, Pomara N, Wolkin A, Rotrosen JP (2002). Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study. Biol Psychiatry 51: 890-895.
54. Lusher J, Chandler C, Ball D (2004). Alcohol dependence and the alcohol Stroop paradigm: evidence and issues. Drug Alcohol Depend 75: 225-231.
55. Lyoo IK, Streeter CC, Ahn KH, Lee HK, Pollack MH, Silveri MM et al (2004). White matter hyperintensities in subjects with cocaine and opiate-dependence and healthy comparison subjects. Psychiatry Res 131: 135-145.
56. Maas LC, Lukas SE, Kaufman MJ, Weiss RD, Daniels SL, Rogers VW et al (1998). Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving. Am J Psychiatry 155: 124-126.
57. MacDonald III AW, Cohen JD, Stenger VA, Carter CS (2000). Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control. Science 288: 1835-1838.
58. MacLeod C (1991). Half a century of research on the Stroop effect: an integrative review. Psychol Bull 109: 163-203.
59. Manschreck TC, Schneyer ML, Weisstein CC, Laughery J, Rosenthal J, Celada T et al (1990). Freebase cocaine and memory. Compr Psychiatry 31: 369-375.
60. Matochik JA, London ED, Eldreth DA, Cadet JL, Bolla KI (2003). Frontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study. Neuroimage 19: 1095-1102.
61. Mayberg H (1997). Limbic-cortical dysregulation. In: Salloway S, Malloy P, Cummings J (eds). The Neuropsychiatry of Limbic and Subcortical Disorders. American Psychiatric Press: Washington, DC. pp 167-178.
62. McLellan A, Kushner H, Metzger D, Peters R, Smith I, Grissom G et al (1992). The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 9: 119-213.
63. Mesulam MM (1985). Principles of Behavioral Neurology. FA Davis Co.: Philadelphia.
64. Miller EK, Cohen JD (2001). An integrative theory of prefrontal cortex function. Annu Rev Neurosci 24: 167-202.
65. Mittenberg W, Motta S (1993). Effects of chronic cocaine abuse on memory and learning. Arch Clin Neuropsychol 8: 477-483.
66. Mulvaney FD, Alterman AI, Boardman CR, Kampman K (1999). Cocaine abstinence symptomatology and treatment attrition. J Subst Abuse Treat 16: 129-135.
67. O'Malley S, Adamse M, Heaton RK, Gawin FH (1992). Neuropsychological impairment in chronic cocaine abusers. Am J Drug Alcohol Abuse 18: 131-144.
68. Pardo JV, Pardo PJ, Janer KW, Raichle ME (1990). The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm. Proc Natl Acad Sci USA 87: 256-259.
69. Peterson BS, Skudlarski P, Gatenby JC, Zhang H, Anderson AW, Gore JC (1999). An fMRI study of Stroop word-color interference: evidence for cingulate subregions subserving multiple distributed attentional systems. Biol Psychiatry 45: 1237-1258.
70. Preston KL, Silverman K, Schuster CR, Cone EJ (1997). Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Addiction 92: 717-727.
71. Simpson D, Joe G, Rowan-Szal G, Greener J (1997). Drug abuse treatment process components that improve retention. J Subst Abuse Treat 14: 565-572.
72. Simpson DD, Joe GW, Fletcher BW, Hubbard RL, Anglin MD (1999). A national evaluation of treatment outcomes for cocaine dependence. Arch Gen Psychiatry 56: 507-514.
73. Siqueland L, Crits-Christoph P, Frank A, Daley D, Weiss R, Chittams J et al (1998). Predictors of dropout from psychosocial treatment of cocaine dependence. Drug Alcohol Depend 52: 1-13.
74. Streeter CC, Hennen J, Ke Y, Jensen JE, Sarid-Segal O, Nassar LE et al (2005). Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment. Psychopharmacology 182: 516-526.
75. Streeter CC, Hennen J, Ke Y, Jensen JE, Sarid-Segal O, Nassar LE et al (2006). Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment. (Erratum) Psychopharmacology 185: 404.
76. Stroop J (1935). Studies of interference in serial verbal reactions. J Exp Psychol 18: 643-662.
77. Teichner G, Horner MD, Roitzsch JC, Herron J, Thevos A (2002). Substance abuse treatment outcomes for cognitively impaired and intact outpatients. Addict Behav 27: 751-763.
78. van Gorp WG, Wilkins JN, Hinkins CH, Moore LH, Hull J, Horner MD et al (1999). Delcarative and procedural memory functioning in abstinent cocaine abusers. Arch Gen Psychiatry 56: 85-89.
79. Volkow ND, Mullani N, Gould KL, Adler S, Krajewski K (1988). Cerebral blood flow in chronic cocaine users: a study with positron emission tomography. Br J Psychiatry 152: 641-648.
80. Waters AJ, Shiffman S, Sayette MA, Paty JA, Gwaltney CJ, Balabanis MH (2003). Attentional bias predicts outcome in smoking cessation. Health Psychol 22: 378-387.
81. Wertz JM, Sayette MA (2001). Effects of smoking opportunity on attentional bias in smokers. Psychol Addict Behav 15: 268-271.
82. Winhusen TM, Somoza EC, Harrer JM, Mezinskis JP, Montgomery MA, Goldsmith RJ et al (2005). A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments. Addiction 100(Suppl 1): 68-77.